logo-loader
LON:CIR

Circassia Pharmaceuticals

Receive alerts
Market:
LON
Market Cap:
£703.47 k
Price
£0.19
Change
-1.32%
52 weeks high
82.70
52 weeks low
13.25

In brief

Circassia is a specialty pharmaceutical company focused on respiratory disease. Our growing commercial organization promotes our innovative asthma management products directly to specialist physicians in a number of key markets, and we market the chronic obstructive pulmonary disease (COPD) product Tudorza® in the United States. We are expanding our commercial platform in China, and are working to expand our portfolio through in-licensing, partnering or acquisition. 

https://www.circassia.com/company/

Insight

Deep dive

Circassia on track to achieve underlying profitability in 2020 after recent US approvals

City broker Peel Hunt reckons the recent approvals “support the top-line forecasts in ou...

on 2/4/19